Press Release: First SB 17 Drug Cost Increase Report Reveals a 25% Median Increase for All Reported Drugs
September 24, 2019, Sacramento, Calif. – The first major quarterly report providing wholesale drug cost increase information on existing prescription drugs issued by the Office of Statewide Health Planning and Development (OSHPD) was released and made available to the public for the first time yesterday. The report is a result of the passage of Senate Bill 17 (Hernandez) - California’s landmark drug price transparency bill that became law in 2017.
Press Release: California Assembly Passes Bill to Address Inflated Medical Claims by Dialysis, Drug Treatment Industries
The California Assembly passed a bill Sept. 10 to address runaway costs and rein in a profiteering scheme involving the dialysis and addiction treatment industries, and it now heads to Gov. Gavin Newsom, who has until Oct. 13 to decide whether to sign it into law.
Your Plan Your Advocate Fact Sheet: Health Plans 101: Covering California's Essential Benefits